Junjie Xu

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Pseudomonas Aeruginosa

Recombinant Human

Dendritic Cells

Respiratory Syndrome Coronavirus

Top Venues

Science (New York, N.Y.)

Microbial biotechnology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, Junjie Xu, Wei Chen
Challenges and developments in universal vaccine design against SARS-CoV-2 variants. NPJ vaccines 7 (1) (2022)
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, Junjie Xu, Wei Chen
Challenges and developments in universal vaccine design against SARS-CoV-2 variants. NPJ vaccines 7 (1) (2022)
Rui Yu, Yunyun Mao, Kai Li, Yanfang Zhai, Yue Zhang, Shuling Liu, Yuemei Gao, Zhengshan Chen, Yanhong Liu, Ting Fang, Mengsu Zhao, Ruihua Li, Junjie Xu, Wei Chen
Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection. Mediators of inflammation 2021 (2021)
Rui Yu, Qingbin Lin, Yanfang Zhai, Yunyun Mao, Kai Li, Yuemei Gao, Yanhong Liu, Ling Fu, Ting Fang, Mengsu Zhao, Lei Guan, Lihua Hou, Junjie Xu, Wei Chen
Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis. Microbial biotechnology 14 (5) (2021)
Xiang-Yang Chi, Renhong Yan, Jun Zhang, Guan-Ying Zhang, Yuanyuan Zhang, Meng Hao, Zhe Zhang, Pengfei Fan, Yunzhu Dong, Yilong Yang, Zhengshan Chen, Yingying Guo, Jin-Long Zhang, Yaning Li, Xiaohong Song, Yi Chen, Lu Xia, Ling Fu, Lihua Hou, Junjie Xu, Changming Yu, Jianmin Li, Qiang Zhou, Wei Chen
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science (New York, N.Y.) 369 (6504) (2020)
Shipo Wu, Gongxun Zhong, Jun Zhang, Lei Shuai, Zhe Zhang, Zhiyuan Wen, Busen Wang, Zhenghao Zhao, Xiaohong Song, Yi Chen, Renqiang Liu, Ling Fu, Jin-Long Zhang, Qiang Guo, Chong Wang, Yilong Yang, Ting Fang, Peng Lv, Jinliang Wang, Junjie Xu, Jianmin Li, Changming Yu, Li-Hua Hou, Zhi-Gao Bu, Wei Chen
A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nature communications 11 (1) (2020)